Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Aug 18;9(8):2677.
doi: 10.3390/jcm9082677.

Macular Perfusion Impairment in Von Hippel-Lindau Disease Suggests a Generalized Retinal Vessel Alteration

Affiliations

Macular Perfusion Impairment in Von Hippel-Lindau Disease Suggests a Generalized Retinal Vessel Alteration

Elisabetta Pilotto et al. J Clin Med. .

Abstract

Background: To evaluate macular perfusion in patients with Von Hippel-Lindau (VHL) disease.

Methods: VHL patients with or without peripheral retinal hemangioblastomas (RHs) were consecutively enrolled. A group of healthy subjects served as controls. Macular perfusion was analyzed by means of OCT angiography (OCTA) in the superficial vascular plexus (SVP), and in the intermediate (ICP) and deep retinal capillary (DCP) plexuses. The following OCTA parameters were measured: Vessel Area Density (VAD), Vessel Length Fraction (VLF), Vessel Diameter Index (VDI) and Fractal Dimension (FD).

Results: Sixty-three VHL patients (113 eyes) and 28 healthy controls (56 eyes) were enrolled. All OCTA quantitative parameters were reduced in VHL patients vs. controls, reaching statistical significance for VAD of the SVP (0.348 ± 0.07 vs. 0.369 ± 0.06, p = 0.0368) and VDI of all plexuses (p < 0.03 for all). No significant differences were detected between eyes without or with peripheral RHs.

Conclusions: Macular perfusion is reduced in VHL patients demonstrating retinal vessel changes that are independent of the presence of peripheral RHs. VHL gene mutations disrupt the hypoxia-induced (HIF)/vascular endothelium growth factors (VEGF) pathway and the Notch signaling, both essential for the normal retinal vasculogenesis and angiogenesis. Therefore, an anomalous generalized retinal vascular development may be hypothesized in VHL disease.

Keywords: OCT; OCT angiography; Von Hippel Lindau disease; macular flow; retinal hemangioblastoma; retinal vascular plexuses.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
En-face OCT angiography (OCTA) and corresponding binary images of an eye of a Von Hippel–Lindau (VHL) patient (DF,JL) and of a healthy control (AC,GI) of the superficial vascular plexus (SVP, A,D), of the intermediate capillary plexus (ICP, B,E) and of the deep capillary plexus (DCP, C,F). In the VHL eye a reduction of the vessel density is detectable, mainly at the SVP level.

References

    1. Aronow M., Wiley H., Gaudric A., Krivosic V., Gorin M.B., Shields C., Shields J.A., Jonasch E.W., Singh A.D., Chew E.Y. Von Hippel-Lindau Disease: Update on Pathogenesis and Systemic Aspects. Retina. 2019;39:2243–2253. doi: 10.1097/IAE.0000000000002555. - DOI - PubMed
    1. Von Hippel E. Die anatomische Grundlage der von mir beschriebenen “sehr seltenen Erkrankung der Netzhaut”. Arch. Opthalmol. 1911;79:350–377. doi: 10.1007/BF01966371. - DOI
    1. Lindau A. Zur Frage der Angiomatosis Retinae und ihrer Hirnkomplikationen. Acta Ophthalmol. Scand. 1927;4:193–226. doi: 10.1111/j.1755-3768.1926.tb07786.x. - DOI
    1. Hajjaj A., van Overdam K.A., Oldengurg R.A., Koopmans A.E., van den Ouweland A.M., de Klein A., Kiliç E. Retinal haemangioblastomas in von Hippel-Lindau germline mutation carriers: Progression, complications and treatment outcome. Acta Ophthalmol. 2020;98:464–471. doi: 10.1111/aos.14360. - DOI - PMC - PubMed
    1. Dalvin L.A., Yu M.D., Ancona-Lezama D.A., Pulido J.S., Olsen T.W., Shields C.L. Retinal haemangioblastoma associated with peripheral non-perfusion: Widefield fluoresceina angiography analysis of 41 cases. Br. J. Ophthalmol. 2020;104:167–172. doi: 10.1136/bjophthalmol-2019-314021. - DOI - PubMed

LinkOut - more resources